Optimizing the use of CROs by academia and small companies

Rachel F. Lane, Lauren G. Friedman, Curtis Keith, Steven P. Braithwaite, Julie A. Frearson, David A. Lowe, Frank M. Longo, Lorenzo M. Refolo, D. Martin Watterson, Katherine Tsaioun, Diana W. Shineman, Howard M. Fillit

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)487-488
Number of pages2
JournalNature Reviews Drug Discovery
Volume12
Issue number7
DOIs
StatePublished - Jul 2013
Externally publishedYes

Fingerprint

Interdisciplinary Communication
Contract Services
Pharmaceutical Technology
Capacity Building
Drug Discovery

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology

Cite this

Lane, R. F., Friedman, L. G., Keith, C., Braithwaite, S. P., Frearson, J. A., Lowe, D. A., ... Fillit, H. M. (2013). Optimizing the use of CROs by academia and small companies. Nature Reviews Drug Discovery, 12(7), 487-488. https://doi.org/10.1038/nrd4057

Optimizing the use of CROs by academia and small companies. / Lane, Rachel F.; Friedman, Lauren G.; Keith, Curtis; Braithwaite, Steven P.; Frearson, Julie A.; Lowe, David A.; Longo, Frank M.; Refolo, Lorenzo M.; Watterson, D. Martin; Tsaioun, Katherine; Shineman, Diana W.; Fillit, Howard M.

In: Nature Reviews Drug Discovery, Vol. 12, No. 7, 07.2013, p. 487-488.

Research output: Contribution to journalArticle

Lane, RF, Friedman, LG, Keith, C, Braithwaite, SP, Frearson, JA, Lowe, DA, Longo, FM, Refolo, LM, Watterson, DM, Tsaioun, K, Shineman, DW & Fillit, HM 2013, 'Optimizing the use of CROs by academia and small companies', Nature Reviews Drug Discovery, vol. 12, no. 7, pp. 487-488. https://doi.org/10.1038/nrd4057
Lane RF, Friedman LG, Keith C, Braithwaite SP, Frearson JA, Lowe DA et al. Optimizing the use of CROs by academia and small companies. Nature Reviews Drug Discovery. 2013 Jul;12(7):487-488. https://doi.org/10.1038/nrd4057
Lane, Rachel F. ; Friedman, Lauren G. ; Keith, Curtis ; Braithwaite, Steven P. ; Frearson, Julie A. ; Lowe, David A. ; Longo, Frank M. ; Refolo, Lorenzo M. ; Watterson, D. Martin ; Tsaioun, Katherine ; Shineman, Diana W. ; Fillit, Howard M. / Optimizing the use of CROs by academia and small companies. In: Nature Reviews Drug Discovery. 2013 ; Vol. 12, No. 7. pp. 487-488.
@article{6074f0ba3e0b4491bd5aaa3d95bb4096,
title = "Optimizing the use of CROs by academia and small companies",
author = "Lane, {Rachel F.} and Friedman, {Lauren G.} and Curtis Keith and Braithwaite, {Steven P.} and Frearson, {Julie A.} and Lowe, {David A.} and Longo, {Frank M.} and Refolo, {Lorenzo M.} and Watterson, {D. Martin} and Katherine Tsaioun and Shineman, {Diana W.} and Fillit, {Howard M.}",
year = "2013",
month = "7",
doi = "10.1038/nrd4057",
language = "English (US)",
volume = "12",
pages = "487--488",
journal = "Nature Reviews Drug Discovery",
issn = "1474-1776",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Optimizing the use of CROs by academia and small companies

AU - Lane, Rachel F.

AU - Friedman, Lauren G.

AU - Keith, Curtis

AU - Braithwaite, Steven P.

AU - Frearson, Julie A.

AU - Lowe, David A.

AU - Longo, Frank M.

AU - Refolo, Lorenzo M.

AU - Watterson, D. Martin

AU - Tsaioun, Katherine

AU - Shineman, Diana W.

AU - Fillit, Howard M.

PY - 2013/7

Y1 - 2013/7

UR - http://www.scopus.com/inward/record.url?scp=84879665511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879665511&partnerID=8YFLogxK

U2 - 10.1038/nrd4057

DO - 10.1038/nrd4057

M3 - Article

C2 - 23812255

AN - SCOPUS:84879665511

VL - 12

SP - 487

EP - 488

JO - Nature Reviews Drug Discovery

JF - Nature Reviews Drug Discovery

SN - 1474-1776

IS - 7

ER -